Walleye Trading
LMDXW

Walleye Trading’s LumiraDx Limited Warrant LMDXW Stock Holding History

Walleye Trading’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$172 – 5643
2023
Q4 		$172 Hold
20,000
– – ﹤0.01% 5000
2023
Q3 		$580 Hold
20,000
– – ﹤0.01% 4913
2023
Q2 		$598 Hold
20,000
– – ﹤0.01% 4611
2023
Q1 		$2.35K Hold
20,000
– – ﹤0.01% 4619
2022
Q4 		$1.18K Hold
20,000
– – ﹤0.01% 4792
2022
Q3 		$2K Hold
20,000
– – ﹤0.01% 4824
2022
Q2 		$18K Hold
20,000
– – ﹤0.01% 4541
2022
Q1 		$17K Hold
20,000
– – ﹤0.01% 4808
2021
Q4 		$36K Hold
20,000
– – ﹤0.01% 4764
2021
Q3 		$23K Buy
+20,000
New +$23.2K ﹤0.01% 4842

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Walleye Trading's LMDXW Position: Q1 2024 in Review

Walleye Trading sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2024, closing a stake of 20,000 shares — an estimated $172 sold.

Walleye Trading first reported a position in LMDXW in Q3 2021 and held it in 10 quarters. The position peaked at $36K in Q4 2021. 4 funds tracked by Wall St. Rank hold LMDXW as of Q1 2024.

  • Walleye Trading reported no remaining LumiraDx Limited Warrant position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 20,000 LumiraDx Limited Warrant shares in Q1 2024, an estimated $172.
  • Walleye Trading first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 10 quarters.
  • Walleye Trading's LumiraDx Limited Warrant position peaked at $36K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.